Monday, November 4, 2019

Krystal Biotech EPS beats by $0.14

Krystal Biotech (NASDAQ:KRYS): Q3 GAAP EPS of -$0.25 beats by $0.14.
Cash, cash equivalents and short-term investments of $203.2M.
Press Release
at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.